Guiyun Zhou

Keywords metabolic dysfunction-associated steatotic liver disease gut microbiota resistant starch treatment effect heterogeneity prebiotics precision medicine multi-omics Bifidobacterium pseudocatenulatum Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD), previously recognized as non-alcoholic fatty liver disease (NAFLD), is gaining increasing attention as a global health crisis.1 It encompasses a spectrum ranging from simple steatosis to metabolic...

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.